NEJM: Modern's vaccine is more effective than Pfizer's

In a new study published yesterday (Wednesday) in the New England Journal of Medicine and reported by the New York Times , a comparison was made “in the real world” between the effectiveness of a company’s vaccine Pfizer compared to that of a modern company. While the two innovative mRNA-based vaccines have been approved for use it has been said that in terms of efficacy they are both equal. But now it turns out from the new study that the data indicate a little differently: there is a difference, even if it is small, in favor of a “modern” vaccine.

Roughly speaking, about 221 million doses of the “Pfizer” vaccine have already been issued For vaccination in the United States, compared to about 150 million of the “Modern” vaccine. About five comparative studies have been published recently, the most recent of which, as stated in “New England”, and the conclusion that emerges from them: Vaccination “Modern” seems to provide greater protection than the Pfizer vaccine months after the injection.

The latest study evaluated efficacy in the “real world” to prevent symptomatic disease among about 5,000 health care professionals And nurses in 25 U.S. states. The effectiveness of the Pfizer vaccine was found to be 88.8%, while that of the Modern is 96.3%. It was also found that the effectiveness of a “modern” vaccine for the prevention of serious illness is in the range of between 92% and 100%, with the Pfizer vaccine lagging behind by about 15% -10%. It was also found that compared to the Delta variant, the “Modern” vaccine is about 30% more effective in prevention.

It was also found that the “Pfizer” vaccine produces one-third to one-half less antibody levels than the one that “Modern” vaccine but the gap is negligible because there are often more than 100 times differences in antibody levels between two healthy people anyway. “Modern” has asked the FDA for approval to give a booster (third dose) at a dose of 50 micrograms – about half the dose of the second dose because the second dose still raises the levels of antibodies in the vaccinated body long after it has been given.

If the gap in efficiency continues to widen, this will also have implications for the debate currently taking place in the US in the context of the booster dose, scientists. Although the difference is not large, it is consistent.

Note: This article has been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Inside The Rs 20 Lakh Presidential Suite Of The Maharajas’ Express thumbnail

Inside The Rs 20 Lakh Presidential Suite Of The Maharajas’ Express

Here’s what you get for Rs 20 lakh for a six-night journey In a video that’s just gone viral, content creator Kushagra shared a sneak-peek of India’s most luxurious train suite — the Presidential Suite of the IRCTC’s famous Maharaja Express. https://www.instagram.com/reel/CllnQdKjnTp/?utm_source=ig_web_copy_link The most expensive train ticket you can book through the Indian Railways, the
Read More
8 Congenital Baby Girls, Complete with Myths and Facts! thumbnail

8 Congenital Baby Girls, Complete with Myths and Facts!

ADA 8 bawaan hamil bayi perempuan yang masih menjadi kepercayaan turun-temurun. Ada beberapa anggapan menyatakan, ibu hamil yang terlihat lebih cantik dari biasanya diartikan sedang mengandung anak bayi perempuan. Sedangkan ibu hamil yang lebih cuek soal penampilan dipercaya tengah mengandung bayi laki-laki. Hal semacam ini akan selalu menarik untuk dibahas. Tapi, apakah memang bawaan hamil…
Read More
Enfortumab Vedotin Promising in Neovadjuvant Therapy in Advanced Bladder Cancer thumbnail

Enfortumab Vedotin Promising in Neovadjuvant Therapy in Advanced Bladder Cancer

Enfortumab vedotin () appeared to be effective as a neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) who were ineligible for cisplatin-based chemotherapy, according to a small phase Ib/II study. Results from a preliminary analysis of 22 patients showed that eight had a pathologic complete response (pCR, 36.4%, 95% CI 17.2-59.3), displaying no signs…
Read More
Hand strikes head... 6-year-old boy who was beaten for a long time, the director also attempted to conceal the incident [Video] thumbnail

Hand strikes head… 6-year-old boy who was beaten for a long time, the director also attempted to conceal the incident [Video]

6세 아동에 위협·폭행한 어린이집 보육교사 CCTV 영상. YTN 보도화면 캡처 6세 아동에 위협·폭행한 어린이집 보육교사 CCTV 영상. YTN 보도화면 캡처 경북 포항의 한 어린이집 보육교사가 6세 남아를 장기간 폭행한 사건이 알려져 공분을 사고 있다. 아이는 심리치료 20회가 필요하다는 진단을 받고, 현재 아동심리치료센터를 방문해 치료를 받고 있는 것으로 알려졌다. 25일 YTN은 보도를 통해 피해 아동이 지난 6월부터 목과 팔에 상처를…
Read More
Who Was Most Protected Against Delta? thumbnail

Who Was Most Protected Against Delta?

Quizzes > Weekly News Quiz — You passed medical training, now see if you can pass our weekly quiz by MedPage Today Staff January 22, 2022 Last Updated January 21, 2022 The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is…
Read More
Index Of News
Total
0
Share